These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 17145534)

  • 21. Conformal radiation therapy for portal vein tumor thrombosis of hepatocellular carcinoma.
    Toya R; Murakami R; Baba Y; Nishimura R; Morishita S; Ikeda O; Kawanaka K; Beppu T; Sugiyama S; Sakamoto T; Yamashita Y; Oya N
    Radiother Oncol; 2007 Sep; 84(3):266-71. PubMed ID: 17716760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma.
    Choi BO; Jang HS; Kang KM; Lee SW; Kang YN; Chai GY; Choi IB
    Jpn J Clin Oncol; 2006 Mar; 36(3):154-8. PubMed ID: 16520355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three-dimensional conformal radiotherapy for hepatocellular carcinoma with inferior vena cava invasion.
    Igaki H; Nakagawa K; Shiraishi K; Shiina S; Kokudo N; Terahara A; Yamashita H; Sasano N; Omata M; Ohtomo K
    Jpn J Clin Oncol; 2008 Jun; 38(6):438-44. PubMed ID: 18495749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility of high-dose three-dimensional radiation therapy in the treatment of localised non-small-cell lung cancer.
    Bellière A; Girard N; Chapet O; Khodri M; Kubas A; Souquet PJ; Mornex F
    Cancer Radiother; 2009 Jul; 13(4):298-304. PubMed ID: 19525134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inclusion of biological factors in parallel-architecture normal-tissue complication probability model for radiation-induced liver disease.
    Cheng JC; Liu HS; Wu JK; Chung HW; Jan GJ
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1150-6. PubMed ID: 15990021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parotid gland-sparing 3-dimensional conformal radiotherapy results in less severe dry mouth in nasopharyngeal cancer patients: a dosimetric and clinical comparison with conventional radiotherapy.
    Jen YM; Shih R; Lin YS; Su WF; Ku CH; Chang CS; Shueng PW; Hwang JM; Liu DW; Chao HL; Lin HY; Chang LP; Shum WY; Lin CS
    Radiother Oncol; 2005 May; 75(2):204-9. PubMed ID: 15908027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Reappraisal of risk factors predicting liver complications from radiotherapy for hepatocellular carcinoma].
    Lee IJ; Seong J; Shim SJ; Han KH; Chon CY
    Korean J Hepatol; 2006 Sep; 12(3):420-8. PubMed ID: 16998294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of active breathing control in 3-dimensional conformal radiation therapy for hepatocellular carcinoma: the feasibility and benefit.
    Zhao JD; Xu ZY; Zhu J; Qiu JJ; Hu WG; Cheng LF; Zhang XJ; Jiang GL
    Radiother Oncol; 2008 Jun; 87(3):439-44. PubMed ID: 18334274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-dimensional conformal radiotherapy of unresectable hepatocellular carcinoma patients for whom transcatheter arterial chemoembolization was ineffective or unsuitable.
    Kim TH; Kim DY; Park JW; Kim YI; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM
    Am J Clin Oncol; 2006 Dec; 29(6):568-75. PubMed ID: 17148993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous multitarget irradiation using helical tomotherapy for advanced hepatocellular carcinoma with multiple extrahepatic metastases.
    Jang JW; Kay CS; You CR; Kim CW; Bae SH; Choi JY; Yoon SK; Han CW; Jung HS; Choi IB
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):412-8. PubMed ID: 18963538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic effects of 3-dimensional conformal radiotherapy for small hepatocellular cancers and multi-factor analysis of the prognosis].
    Wu DH; Chen LH
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1056-8. PubMed ID: 14559693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in Child-Pugh stage A cirrhosis is comparable with liver transplantation.
    Takahashi S; Kudo M; Chung H; Inoue T; Nagashima M; Kitai S; Tatsumi C; Minami Y; Ueshima K; Fukunaga T; Haji S
    Dig Dis; 2007; 25(4):303-9. PubMed ID: 17960064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis.
    Kato H; Tsujii H; Miyamoto T; Mizoe JE; Kamada T; Tsuji H; Yamada S; Kandatsu S; Yoshikawa K; Obata T; Ezawa H; Morita S; Tomizawa M; Morimoto N; Fujita J; Ohto M;
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1468-76. PubMed ID: 15275734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [External radiotherapy for hepatocellular carcinoma].
    Girard N; Mornex F
    Cancer Radiother; 2011 Feb; 15(1):49-53. PubMed ID: 21237691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.
    Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Minami Y; Ueshima K; Haji S
    Oncology; 2007; 72 Suppl 1():98-103. PubMed ID: 18087189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sorafenib in unresectable hepatocellular carcinoma from mild to advanced stage liver cirrhosis.
    Pinter M; Sieghart W; Graziadei I; Vogel W; Maieron A; Königsberg R; Weissmann A; Kornek G; Plank C; Peck-Radosavljevic M
    Oncologist; 2009 Jan; 14(1):70-6. PubMed ID: 19144684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Transarterial chemoembolization and conformal radiotherapy for hepatocellular carcinoma].
    Merle P; Mornex F
    Cancer Radiother; 2011 Feb; 15(1):69-71. PubMed ID: 21237690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three-dimensional conformal radiation therapy and intensity-modulated radiation therapy combined with transcatheter arterial chemoembolization for locally advanced hepatocellular carcinoma: an irradiation dose escalation study.
    Ren ZG; Zhao JD; Gu K; Chen Z; Lin JH; Xu ZY; Hu WG; Zhou ZH; Liu LM; Jiang GL
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):496-502. PubMed ID: 20421145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.
    Wörns MA; Weinmann A; Pfingst K; Schulte-Sasse C; Messow CM; Schulze-Bergkamen H; Teufel A; Schuchmann M; Kanzler S; Düber C; Otto G; Galle PR
    J Clin Gastroenterol; 2009; 43(5):489-95. PubMed ID: 19247201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Three-dimensional conformal radiation therapy for malignant tumors (report of 1,024 cases)].
    Chen LH; Guan J
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Sep; 22(9):853-5. PubMed ID: 12297456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.